Teladoc Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Teladoc Health, Inc. on February 18, 2026. The report discloses corporate governance changes regarding the Board of Directors effective as of the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Expansion: The Board of Directors increased its size to ten members.
- New Appointment: Michael S. Smith was appointed as a director. He was also appointed to the Audit Committee and the Nominating and Corporate Governance Committee.
- Independence Status: The Board determined Mr. Smith is an independent director and an "audit committee financial expert."
- Upcoming Reduction: Following the resignation of Thomas G. McKinley on February 20, 2026, the Board size will decrease to nine members.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. No specific risks or contingencies were disclosed in this report. Mr. Smith's compensation will align with existing arrangements for non-employee directors as described in the Proxy Statement filed on April 8, 2025.
Key Facts for Investor Verification
- Verify the full biographical background and potential conflicts of interest for new director Michael S. Smith.
- Confirm the effective date of Thomas G. McKinley's resignation (February 20, 2026) and the resulting Board composition.
- Review the Company's Proxy Statement filed on April 8, 2025, for details on director compensation programs applicable to Mr. Smith.
- Check the press release dated February 18, 2026 (Exhibit 99.1) for additional context on the appointment.